Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.
Cisplatin is a highly-effective and widely-used chemotherapeutic agent that causes ototoxicity in many patients. Pharmacogenomic studies of key genes controlling drug biotransformation identified variants in thiopurine methyltransferase (TPMT) as predictors of cisplatin-induced ototoxicity, although...
Autors principals: | , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Public Library of Science (PLoS)
2017-01-01
|
Col·lecció: | PLoS ONE |
Accés en línia: | http://europepmc.org/articles/PMC5391095?pdf=render |